The Vaso Shield is a permanent and transparent hydrogel product protected by multiple patents and patent applications, as well as a proprietary manufacturing process, according to the release. It is used commonly during anterior spinal implant procedures and is placed between the spinal implant and the vessels to protect them from subsequent anterior revision surgeries.
The new clearance is for multiple thicknesses ranging from 0.4 mm-1.0 mm.
Read the MiMedx release about the HydroFix Vaso Shield.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
